Learn More
Invitrogen™ Huntingtin Polyclonal Antibody

Description
Neoepitope antibodies distinguish smaller cleaved fragments or processed forms of proteins versus the intact full-length or precursor by using a designed peptide purification process to maximize immunoreactivity to a specific cleavage site. Human HTT caspase cleavage sites generate fragment-specific forms of the protein. Caspase-3/7 has been shown to generate cleavage sites at animo acids 513 and 552. Caspase-2 cleaves at amino acid 552 and caspase-6 at amino acid 586. Neo-specific antibody PA1-004 recognizes the 586 cleaved fragment without detecting the full-length form.
Specifications
Specifications
| Antigen | Huntingtin |
| Applications | ELISA, Immunohistochemistry (Frozen), Western Blot, Immunocytochemistry |
| Classification | Polyclonal |
| Concentration | 0.6 mg/mL |
| Conjugate | Unconjugated |
| Formulation | PBS with 1mg/mL BSA and 0.05% sodium azide |
| Gene | Htt |
| Gene Accession No. | P42858, P42859 |
| Gene Alias | AI256365; C430023I11Rik; Hd; HD protein; HD protein homolog; Hdh; HTT; Huntingtin; huntingtin (Huntington disease); Huntingtin, myristoylated N-terminal fragment; Huntington disease gene homolog; huntington disease protein; huntington disease protein homolog; IT15; solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
| Gene Symbols | Htt |
| Show More |
Safety and Handling
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.